Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351(10):998–1012.
Article
CAS
PubMed
Google Scholar
Tiwary S, Preziosi M, Rothberg PG, Zeitouni N, Corson N, Xu L. ERBB3 is required for metastasis formation of melanoma cells. Oncogenesis. 2014;3:e110.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F, Jemal A, Yu X, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Article
PubMed
Google Scholar
Miller K, Nogueira L, Mariotto A, Rowland J, Yabroff K, Alfano C, Jemal A, Kramer J, Siegel R. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.
Article
PubMed
Google Scholar
Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S. Melanoma. Lancet. 2018;392(10151):971–84.
Article
PubMed
Google Scholar
Moran B, Silva R, Perry A, Gallagher W. Epigenetics of malignant melanoma. Semin Cancer Biol. 2018;51:80–8.
Article
CAS
PubMed
Google Scholar
Strub T, Martel A, Nahon-Esteve S, Baillif S, Ballotti R, Bertolotto C. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology. Prog Retinal Eye Res. 2021. https://doi.org/10.1016/j.preteyeres.2021.100968.
Article
Google Scholar
AlDubayan S, Conway J, Camp S, Witkowski L, Kofman E, Reardon B, Han S, Moore N, Elmarakeby H, Salari K, et al. Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma. JAMA. 2020;324(19):1957–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu Q, Lian J, Stein J, Stein G, Nickerson J, Imbalzano A. The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer. Epigenomics. 2017;9(6):919–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang H, Weng H, Chen J. mA modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270–88.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Z, Lv J, Yu H, Han J, Yang X, Feng D, Wu Q, Yuan B, Lu Q, Yang H. Mechanism of RNA modification N6-methyladenosine in human cancer. Mol Cancer. 2020;19(1):104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anita R, Paramasivam A, Priyadharsini JV, Chitra S. The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res. 2020;10(8):2546–54.
CAS
PubMed
PubMed Central
Google Scholar
Chen M, Nie ZY, Wen XH, Gao YH, Cao H, Zhang SF. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. 2019. Biosci Rep. https://doi.org/10.1042/BSR20192892.
Article
PubMed
PubMed Central
Google Scholar
Deng X, Jiang Q, Liu Z, Chen W. Clinical significance of an m6A reader gene, IGF2BP2, in head and neck squamous cell carcinoma. Front Mol Biosci. 2020;7:68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Du J, Hou K, Mi S, Ji H, Ma S, Ba Y, Hu S, Xie R, Chen L. Malignant evaluation and clinical prognostic values of m6A RNA methylation regulators in glioblastoma. Front Oncol. 2020;10:208.
Article
PubMed
PubMed Central
Google Scholar
Ji L, Chen S, Gu L, Zhang X. Exploration of potential roles of m6A regulators in colorectal cancer prognosis. Front Oncol. 2020;10:768.
Article
PubMed
PubMed Central
Google Scholar
Wang L, Chen S, Shen X, Li D, Liu H, Ji Y, Li M, Yu K, Yang H, Chen J, et al. M6A RNA methylation regulator HNRNPC contributes to tumorigenesis and predicts prognosis in glioblastoma multiforme. Front Oncol. 2020;10:536875.
Article
PubMed
PubMed Central
Google Scholar
Wang M, Yang Y, Yang J, Yang J, Han S. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of mA-YTHDF3-Zeb1. Life Sci. 2020;257:118082.
Article
CAS
PubMed
Google Scholar
Hou J, Shan H, Zhang Y, Fan Y, Wu B. mA RNA methylation regulators have prognostic value in papillary thyroid carcinoma. Am J Otolaryng. 2020;41(4):102547.
Article
CAS
Google Scholar
Tang J, Wan Q, Lu J. The prognostic values of m6A RNA methylation regulators in uveal melanoma. BMC Cancer. 2020;20(1):674.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin Y, Wang S, Liu S, Lv S, Wang H, Li F, Zhu S. Identification and verification of molecular subtypes with enhanced immune infiltration based on m6A regulators in cutaneous melanoma. Biomed Res Int. 2021;2021:1–19.
Google Scholar
Ye W, Luo C, Liu F, Liu Z, Chen F. CD96 correlates with immune infiltration and impacts patient prognosis: a pan-cancer analysis. Front Oncol. 2021;11:634617.
Article
PubMed
PubMed Central
Google Scholar
Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox’s proportional hazards model via coordinate descent. J Stat Softw. 2011;39(5):1–13.
Article
PubMed
PubMed Central
Google Scholar
Li M, Lin A, Luo P, Shen W, Xiao D, Gou L, Zhang J, Guo L. DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer. Aging. 2020;12(2):1285–303.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brunner G, Reitz M, Heinecke A, Lippold A, Berking C, Suter L, Atzpodien J. A nine-gene signature predicting clinical outcome in cutaneous melanoma. J Cancer Res Clin Oncol. 2013;139(2):249–58.
Article
CAS
PubMed
Google Scholar
Liu N, Liu Z, Liu X, Duan X, Huang Y, Jin Z, Niu Y, Zhang L, Chen H. Identification of an immune-related prognostic signature associated with immune infiltration in melanoma. Front Genet. 2020;11:1002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyer S, Fuchs TJ, Bosserhoff AK, Hofstadter F, Pauer A, Roth V, Buhmann JM, Moll I, Anagnostou N, Brandner JM, et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One. 2012;7(6):e38222.
Article
CAS
PubMed
PubMed Central
Google Scholar
Randerson-Moor J, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop J, et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet. 2001;10(1):55–62.
Article
CAS
PubMed
Google Scholar
Goldstein A, Chan M, Harland M, Hayward N, Demenais F, Bishop D, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99–106.
Article
CAS
PubMed
Google Scholar
Zhang L, Lv S, Sun C, Wan L, Tan H, Zhang Y. Effect of MAH-g-PLA on the properties of wood fiber/polylactic acid composites. Polymers. 2017;9(11):591.
Article
PubMed Central
CAS
Google Scholar
Roignant J, Soller M. mA in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genetics. 2017;33(6):380–90.
Article
CAS
Google Scholar
Ma J, Yang F, Zhou C, Liu F, Yuan J, Wang F, Wang T, Xu Q, Zhou W, Sun S. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N -methyladenosine-dependent primary MicroRNA processing. Hepatology (Baltimore, MD). 2017;65(2):529–43.
Article
CAS
Google Scholar
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N-Methyladenosine RNA demethylase. Cancer Cell. 2017;31(1):127–41.
Article
PubMed
CAS
Google Scholar
Lin S, Choe J, Du P, Triboulet R, Gregory R. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dahal U, Le K, Gupta M. RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2. Melanoma Res. 2019;29(4):382–9.
Article
CAS
PubMed
Google Scholar
Hao L, Yin J, Yang H, Li C, Zhu L, Liu L, Zhong J. ALKBH5-mediated mA demethylation of FOXM1 mRNA promotes progression of uveal melanoma. Aging. 2021. https://doi.org/10.18632/aging.202371.
Article
PubMed
PubMed Central
Google Scholar
Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, Agrawal K, Gonzalez G, Wang Y, Patel S, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117(33):20159–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang S, Wei J, Cui Y, Park G, Shah P, Deng Y, Aplin A, Lu Z, Hwang S, He C, et al. mA mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10(1):2782.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jia R, Chai P, Wang S, Sun B, Xu Y, Yang Y, Ge S, Jia R, Yang Y, Fan X. mA modification suppresses ocular melanoma through modulating HINT2 mRNA translation. Mol Cancer. 2019;18(1):161.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu J, Sun G, Pan S, Qin M, Ouyang R, Li Z, Huang J. The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma. Bioengineered. 2020;11(1):759–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gu C, Shi X, Qiu W, Huang Z, Yu Y, Shen F, Chen Y, Pan X. Comprehensive analysis of the prognostic role and mutational characteristics of m6A-related genes in lung squamous cell carcinoma. Front Cell Dev Biol. 2021;9:661792.
Article
PubMed
PubMed Central
Google Scholar
Chen L, Hu B, Song X, Wang L, Ju M, Li Z, Zhou C, Zhang M, Wei Q, Guan Q, et al. mA RNA methylation regulators impact prognosis and tumor microenvironment in renal papillary cell carcinoma. Front Oncol. 2021;11:598017.
Article
PubMed
PubMed Central
Google Scholar
Meng Z, Yuan Q, Zhao J, Wang B, Li S, Offringa R, Jin X, Wu H. The mA-related mRNA signature predicts the prognosis of pancreatic cancer patients. Mol Ther Oncolytics. 2020;17:460–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yeon S, Jo Y, Choi E, Kim M, Yoo N, Lee S. Frameshift mutations in repeat sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 genes in colon cancers. Pathol Oncol Res. 2018;24(3):617–22.
Article
CAS
PubMed
Google Scholar
Liu X, Liu L, Dong Z, Li J, Yu Y, Chen X, Ren F, Cui G, Sun R. Expression patterns and prognostic value of mA-related genes in colorectal cancer. Am J Transl Res. 2019;11(7):3972–91.
CAS
PubMed
PubMed Central
Google Scholar
Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, Wang F. m6A regulators is differently expressed and correlated with immune response of esophageal cancer. Front Cell Dev Biol. 2021;9:650023.
Article
PubMed
PubMed Central
Google Scholar
Schmiedel D, Tai J, Yamin R, Berhani O, Bauman Y, Mandelboim O. The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. eLife. 2016. https://doi.org/10.7554/eLife.13426.
Article
PubMed
PubMed Central
Google Scholar
Guo W, Zhu L, Zhu R, Chen Q, Wang Q, Chen J. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma. eLife. 2019;8:e44310.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zeng Y, Zeng Y, Yin H, Chen F, Wang Q, Yu X, Zhou Y. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma. Aging. 2021;13(3):3459–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luo H, Ma C, Shao J, Cao J. Prognostic implications of novel ten-gene signature in uveal melanoma. Front Oncol. 2020;10:567512.
Article
PubMed
PubMed Central
Google Scholar
Huang L, Chen H, Xu Y, Chen J, Liu Z, Xu Q. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis. Cancer Med Us. 2020;9(22):8444–56.
Article
CAS
Google Scholar
Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt M, Bürdek M, Berking C, Prinz J. Clonality of CD4 blood T cells predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma. Front Immunol. 2019;10:1336.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu H, Innamarato P, Kodumudi K, Weber A, Nemoto S, Robinson J, Crago G, McCardle T, Royster E, Sarnaik A, et al. Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1. Oncotarget. 2016;7(25):37893–905.
Article
PubMed
PubMed Central
Google Scholar
Marconcini R, Galli L, Antonuzzo A, Bursi S, Roncella C, Fontanini G, Sensi E, Falcone A. Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months. Exp Hematol Oncol. 2017;6:6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ross K, Chin K, Kim D, Marion C, Yen T, Bhattacharjee V. BRAFMethotrexate sensitizes drug-resistant metastatic melanoma cells to V600E inhibitors dabrafenib and encorafenib. Oncotarget. 2018;9(17):13324–36.
Article
PubMed
PubMed Central
Google Scholar
Ross K, Andrews A, Marion C, Yen T, Bhattacharjee V. Identification of the serine biosynthesis pathway as a critical component of BRAF inhibitor resistance of melanoma, pancreatic, and non-small cell lung cancer cells. Mol Cancer Ther. 2017;16(8):1596–609.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daphu I, Horn S, Stieber D, Varughese J, Spriet E, Dale H, Skaftnesmo K, Bjerkvig R, Thorsen F. In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways. Int J Mol Sci. 2014;15(5):8773–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu XR, Chen Z, Liu Y, Chen ZZ, Tang F, Chen ZZ, Li JJ, Liao JL, Cao K, Chen X et al: Prognostic signature and immune efficacy of m A-, m C- and m A-related regulators in cutaneous melanoma. J Cell Mol Med 2021.
Zhang H, Hu J, Liu A, Qu H, Jiang F, Wang C, Mo S, Sun P. An N6-methyladenosine-related gene set variation score as a prognostic tool for lung adenocarcinoma. Front Cell Dev Biol. 2021;9:651575.
Article
PubMed
PubMed Central
Google Scholar